GlassScriptPhysician profile
Anthony B Agrios
NPI 1417920901
$12,562.86
in general payments reported to CMS, 2019-2025
21 companies · $3,545 in 2025
The $3,545 reported for 2025 was more than what 92% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $100 · 2021: $809 · 2022: $198 · 2023: $6,675 · 2024: $1,129 · 2025: $3,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Travel and Lodging: $1,550 · Food and Beverage: $676 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Travel and Lodging | $1,549.54 |
| Food and Beverage | $676.21 |
| Education | $123.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $11,590.78 | 2020-2025 | Gelpoint V-Path |
| Astellas Pharma US INC | $269.14 | 2022-2025 | Veozah, Myrbetriq |
| Cook Medical LLC | $150.45 | 2020-2025 | Zilver Ptx, Torcon Nb |
| Abbvie INC. | $107.97 | 2019-2025 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $67.62 | 2023-2025 | Myfembree |
| Minerva Surgical, INC | $62.97 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.23 | 2023 | |
| Hologic Sales and Service, LLC | $34.92 | 2022-2023 | Aptima |
| Mayne Pharma Commercial LLC | $34.21 | 2025 | |
| Exeltis, USA INC. | $33.26 | 2023-2025 | Slynd |
| Pfizer INC. | $23.04 | 2023 | |
| Exact Sciences Corporation | $21.51 | 2025 | Cologuard Collection Kit |
| Olympus America INC. | $20.32 | 2023 | |
| Lsi Solutions INC | $18.15 | 2023 | Running Device, Fornisee, Ti Knot |
| Avion Pharmaceuticals | $16.91 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.79 | 2019 | |
| Glaxosmithkline, LLC. | $15.78 | 2022 | |
| Lupin INC. | $15.30 | 2019 | |
| Allergan, INC. | $12.61 | 2019 | |
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Agrios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.